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Fetal autopsy is commonly recommended in cases of fetal
anomaly of unknown etiology and fetal demise.1Historically,
autopsy was a common practice after terminations to ascer-
tain ultrasound accuracy.2–4 More recently, however, fetal
autopsy is being performed less frequently, especially when
the reason for the anomaly is known, such as with chromo-
somal abnormalities.2–5 In cases of multiple or complex
malformations of undetermined cause, fetal autopsy often
is still performed.3,4
Fetal autopsy can serve as a quality assurancemeasure for
prenatal diagnostic tools, which may provide psychological
beneﬁt for patients, and can help to elucidate the etiology of
Keywords
► fetal autopsy
► pregnancy
termination
► anomalies
► pregnancy
complications
► recurrence risk
Abstract Objective Historically, fetal autopsy was common after terminations for anomalies.
Previous studies report that fetal autopsy conﬁrms ultrasound ﬁndings in the majority
of cases. This study aims to examine correlation between prenatal and autopsy
diagnoses at University of California, San Francisco (UCSF) and evaluate whether
autopsy adds diagnostic information, speciﬁcally information that changes risk of
recurrence for future pregnancies.
Study Design We conducted a retrospective chart review of all fetal autopsies
performed at UCSF between 1994 and 2009. Prenatal diagnosis was compared with
autopsy diagnosis; for cases where there was a change in diagnosis, an MFM (maternal-
fetal medicine specialist) reviewed the case to assign risk of recurrence before and after
autopsy.
Results Overall, there was concordance between prenatal diagnosis and autopsy
diagnosis in greater than 91.7% of cases. Autopsy added information that resulted in a
change in recurrence risk in 2.3% of cases (n ¼ 9).
Conclusion For the vast majority of cases, there is agreement between prenatal and
autopsy diagnosis after pregnancy loss or termination for fetal anomalies. Only a small
percentage of autopsies change recurrence risk. This may be useful when counseling
women about method of termination and when counseling couples about whether to
have an autopsy.
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intrauterine fetal demise.4 Determining the cause of demise or
anomaly that led to pregnancy loss or termination is important
not only to determine the recurrence risk but also to identify
options to avoid recurrence, for example, using gamete donors or
preimplantation genetic diagnosis. In addition, as an increasing
number of causative genes are identiﬁed, autopsy can help to
guide genetic testing for suspected disorders. In cases, inwhich a
speciﬁc genemutation is identiﬁed, this can be used for prenatal
diagnosis with chorionic villus sampling (CVS) or amniocentesis.
Most studies report that fetal autopsy conﬁrms ultrasound
ﬁndings in the majority of cases, with additional ﬁndings dis-
covered in a wide range of cases (2–50% of autopsies).2–14
Ultrasound and autopsy ﬁndings correlate most closely in cases
of major central nervous system (CNS)12,15,16 and genitourinary
abnormalities; autopsy adds the most information in cases of
cardiac, facial, and musculoskeletal abnormalities, information
that may prove useful in counseling patients about their risk of
recurrence in subsequent pregnancies.
We aimed to investigate correlation of speciﬁc prenatal
diagnoses with fetal autopsy ﬁndings and change in recur-
rence risk according to fetal autopsy ﬁndings overall and for
speciﬁc diagnoses. This information could be useful in coun-
seling patients about whether to pursue additional testing
and may affect healthcare providers’ recommendations for
particular prenatal diagnoses.
Methods
Weperformed a retrospective cohort reviewof all fetal autop-
sies performed at the University of California, San Francisco
(UCSF), a tertiary care referral center, between 1994 and 2009.
We identiﬁed all fetal autopsies performed in this time period
from a database maintained in the pathology department.
Specialists in developmental pathology complete all fetal
autopsies at UCSF according to standard practices.
We included all autopsies performed in cases of intrau-
terine fetal demise, termination for anomalies, or fetuses
delivered but not resuscitated. Reasons for termination
included preterm premature rupture of membranes
(PPROM), previable preterm labor, genetic (genetic anomaly,
meaning diagnosis through CVS, or amniocentesis) and/or
structural anomalies, andmaternal indications. We included
fetuses that were a part of a multiple pregnancy individually.
We excluded cases in which the fetus survived more than
6 hours after delivery and terminations that were done for
reasons other than anomalies or pregnancy complications.
We excluded cases with any documentation of resuscitation
efforts. We also excluded cases of preterm delivery and
subsequent neonatal death, as we could not exclude the
possibility of attempted resuscitation. We excluded cases
in which the fetus was sent from an outside institution
postmortem for autopsy, as there was minimal documenta-
tion about prenatal diagnosis available, and therefore we
could not verify the quality of prenatal diagnostic methods.
In addition, we excluded cases where only a partial autopsy
was performed (i.e., CNS only) and those where either
prenatal or postnatal information was unavailable. We
reviewed medical charts for all cases of fetal autopsy that
met our inclusion criteria. The data we abstracted included
fetal autopsy reports, prenatal testing information and diag-
noses (i.e., ultrasound ﬁndings, number of ultrasounds per-
formed, additional imaging), and amniocentesis or chorionic
villus sampling results. We reviewed ultrasound reports and
when reports were unavailable, we reviewed descriptions of
ultrasound ﬁndings in clinical notes. We included the latter
because, though they were incomplete, they still provided
useful summaries of prenatal diagnosis. We also collected the
following data onmaternal and fetal characteristics: maternal
age, gravidity, and parity, gestational age at the time of
delivery/dilation and evacuation, andmode of delivery (induc-
tion of labor, dilation and evacuation, or other). This studywas
approved by the Committee on Human Research at UCSF.
We compared prenatal diagnoses to autopsy diagnoses for
all cases. Maternal-fetalmedicine subspecialists (J.V., M.E.N.)
reviewed all caseswith disparateﬁndings. For each case, they
assigned recurrence risk before autopsy to be low risk (<
25%), high risk (> 25%), or unknown; and recurrence risk
after autopsy to be low risk, high risk, or unknown. Then, they
determined change in recurrence for each case as follows: no
change, change from low risk to high risk, change from high
risk to low risk, or unknown.We used descriptive analyses by
reporting proportions of change in recurrence risk overall
and according to particular diagnoses.
Results
A total of 434 fetal autopsies were performed during the
study period. We excluded 49 cases, which left 385 cases for
analysis (►Fig. 1).
Total number of fetal
autopsies: 434
25 excluded because did
not undergo a procedure for 
termination or fetal demise
and/or lived ≥ 6 hours*   
No antenatal records
(n = 6) 
No autopsy report found
(n = 4)
Case from outside
institution (n = 2)
No identified maternal or
fetal indication (n = 1) Total autopsies for
analysis: 385
Partial autopsy only
(n = 11)
Fig. 1 Exclusions and total autopsies for analysis. Documentation of
any resuscitation efforts and/or neonate lived > 6 hours following
delivery.
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The mean age of women for whom fetal autopsies were
performed was 29 years, with an average gestational age at
time of delivery or termination of 235/7 weeks (►Table 1).
Approximately one-third of women were white and one-
third of themwere other/unknown. Most terminations were
accomplished by induction of labor (n ¼ 356; 92.5%), with
the remainder done by dilation and evacuation (n ¼ 11;
2.9%), or other methods including hysterotomy and unspe-
ciﬁed methods (n ¼ 18; 4.7%). Notably, 71 (18.4%) of the
fetuses included in this study were the product of a multiple
pregnancy (twins or triplets). Structural anomalies were the
most common reason for autopsy (n ¼ 154; 40%) followed by
intrauterine fetal demise (n ¼ 107; 27.8%).
Overall, there was agreement between prenatal diagnosis
and autopsy diagnosis in greater than 91.7% of cases. Autopsy
added information that resulted in a change in recurrence
risk in 2.3% of cases (n ¼ 9; ►Table 2).
For cases of prenatally diagnosed structural abnormal-
ities, 17.5% (n ¼ 27) had a change in diagnosis; of these, 3.9%
(n ¼ 6; 1.6% of total cases) had a change in recurrence risk
based on autopsy ﬁndings. We observed the highest inci-
dence of change in diagnosis in cases of musculoskeletal
anomalies (40%; n ¼ 5), neurological anomalies (23.3%;
n ¼ 9), and multiple anomalies (18.9%; n ¼ 10). Cases of
intrauterine growth restriction/oligohydramnios and facial
anomalies had high incidence but only one or two cases of
each (►Fig. 2). Reasons for termination with the highest
incidence of change in recurrence risk were neurological
(10%; n ¼ 3) and genitourinary (5.2%; n ¼ 1), followed by
multiple anomalies (3.8%; n ¼ 2).
Of the 48 autopsies performed for intrauterine fetal
demise with a known anomaly (i.e., diagnosed prenatally),
therewere two cases inwhich autopsy provided information
that changed recurrence risk from low to high. In the 42
autopsies done for preterm previable PPROM, three had a
change in diagnosis but only two had a change in recurrence
(both low to high).
There were two terminations for structural anomalies in
which autopsies revealed no clear structural malformations.
In one, prenatal ultrasound showed, probable Dandy–
Walker, malformation with inferior vermian agenesis. The
patient was counseled to have a repeat ultrasound in 2weeks
but instead elected to terminate via induction of labor at 204/
7 weeks. In another case, the ultrasound showed an IUGR
fetus with renal agenesis resulting in lung hypoplasia, bilat-
eral ventriculomegaly with possible corpus callosum agen-
esis, and an abnormal placenta; on autopsy, the fetus had no
malformations (though the CNS was too macerated for
complete evaluation) but the placenta showed massive
perivillous ﬁbrin deposition.
Discussion
In this retrospective review of the correlation between
ultrasound and autopsy diagnoses in fetuses that were
terminated, we found full agreement between prenatal and
postnatal diagnosis in 91.7% of cases but a change in recur-
rence risk in only 2.3%.
Our ﬁndings are similar to studies that have found ultra-
sound–autopsy concordance in 29 to 91% of cases.17,18
However, our ﬁndings on the change in recurrence risk differ
from those of other studies that demonstrate a recurrence
risk of 8 to 49%. Boyd et al2 reviewed 309 terminations for
anomalies and found that in 27% of cases, information from
the autopsy changed recurrence risk. In 2007, Dickinson
et al3 conducted a 10-year review of 1,012 terminations
for fetal abnormality and found that in 16% of euploid cases,
Table 1 Characteristics of patients in whom autopsies were
done after pregnancy termination
n (%)
Total 385
Maternal age (y) 29.0 (range: 13–46)
Gestational age at the time of
termination or delivery (wk)
23.7 (range: 14–41.4)
Gravidity 3 (1–15)
Parity 1 (0–6)
Race
White 129 (33.5)
Black 56 (14.5)
Asian/Paciﬁc Islander/Hawaiian 34 (8.8)
Hispanic/Latina 50 (13.0)
Native American 1 (0.3)
Other/unknown 115 (29.9)
Mode of termination
Induction 356 (92.5)
D&E 11 (2.9)
Hysterotomy 8 (2.1)
Unknown 10 (2.6)
Singleton pregnancy 314 (81.6)
Multiple pregnancy 71 (18.4)
Reason for autopsy
Genetic anomaly 29 (7.5)
Structural anomaly 154 (40.0)
Preterm labor (previable) 42 (10.9)
PPROM 44 (11.4)
Intrauterine fetal demise 107 (27.8)
With known anomaly 48 (12.5)
Without known anomaly 59 (15.3)
Maternal morbidity 9 (2.3)
Preeclampsia 5 (1.3)
HELLP syndrome 2 (0.5)
Mirror syndrome 1 (0.3)
Malignancy 1 (0.3)
Abbreviations: D&E, dilation and evacuation; HELLP, hemolysis, elevated
liver enzymes, and low platelets; PPROM, previable preterm premature
rupture of membranes.
American Journal of Perinatology Reports Vol. 9 No. 1/2019
Does Fetal Autopsy Change Recurrence Risk after Pregnancy Loss? Cassidy et al.e32
Table 2 Cases with change in recurrence risk after autopsy
Prenatal diagnosis Autopsy diagnosis Change in recurrence risk
Anhydramnios with bilateral echogenic
kidneys
Renal tubular dysgenesis Unknown to high
Hydrops, bilateral clubfeet, hypokinesis Neu–Laxova Syndrome Unknown to high
Skeletal dysplasia Kyphomelic dysplasia Unknown to high
Dandy–Walker malformation, multiple
anomalies
Fryns’s syndrome Unknown to high
IUFD with intracranial arteriovenous malfor-
mation, high output cardiac failure
No major malformations but severe intrauterine
growth restriction and very small placenta (114
gm, expected 457 gm), IUFD from chronic
hypoxia secondary to placental insufﬁciency
Low to high
Fetal renal agenesis versus severe renal dys-
plasia resulting in anhydramnios and hypo-
plastic lungs
No malformations, placenta with massive peri-
villous ﬁbrin deposition
Low to high
Ventriculomegaly, elevated alpha-fetoprotein Congenital Finnish type nephrotic syndrome Low to high
Elevated maternal alpha-fetoprotein and
human chorionic gonadotropin, possible Fin-
nish nephrosis
Nomajormalformations, kidneys with fused foot
processes consistent with Finnish type congeni-
tal nephrosis
Low to high
Encephalocele, intrauterine growth
restriction
Radial aplasia, meningoencephalocele, cerebellar
hypoplasia consistent with Dandy–Walker variant
Low to unknown
Abbreviation: IUFD, intrauterine fetal demise.
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Structural anomaly type
No change in diagnosis No change in recurrence 
Change in recurrence (low to high) Change in recurrence (unknown to high) 
Change in recurrence (low to unknown) 
Fig. 2 Change in recurrence by reason for termination.
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autopsy added “signiﬁcant or major information”; of these,
therewas a change in recurrence risk in 49% (8% of all euploid
cases). Both hadmuch higher proportions of terminations for
karyotypic abnormalities than ours. Our lower rate reﬂects
the skill of the radiologists at our institution and may also
reﬂect population differences.
There is increasing evidence that minimally invasive fetal
autopsy is a highly accurate alternative to conventional
autopsy.19 Postmortem magnetic resonance imaging (MRI)
is especially useful in the evaluation of many fetal CNS
pathologies, as it may not be as limited by maceration and
autolysis that result from a termination.20–22 The less inva-
sive approach has also been found to have higher accept-
ability among parents.23
In our cohort, the vast majority of fetuses were delivered
via labor induction. It is not explicitly stated in the medical
records why the proportion of labor inductions is so high in
this cohort, though in our cohort most people choosing
autopsy underwent induction.
Notably, among cases of PPROM, preterm labor and
maternal morbidity which made up approximately 25% of
our population, therewas only one case of previable preterm
labor in which estimation of recurrence risk changed after
autopsy. In cases, such as these, autopsy may be less useful,
especially with regards to implications for future
pregnancies.
Strengths of our study include the fact that we looked at
all fetal autopsies performed at our tertiary referral center.
We included a broader gestational age than other compar-
able studies. Our fetal ultrasonographers are expert in dis-
cerning detailed anatomy and our pathologists are highly
trained in fetal autopsy and follow a speciﬁc protocol to
standardize diagnoses.
We had some limitations in the records that were
incorporated due to multiple different medical records
systems over the study period. This meant that for some
cases, we had to rely on clinical notes that summarized
prenatal diagnoses rather than more complete formal ultra-
sound reports. Unfortunately, we were not able to consis-
tently evaluate which patients underwent a postnatal
genetic study (such as karyotype, microarray, or other
analysis); nor were we able to consistently evaluate which
patients underwent postnatal MRI. The results from this
testing were not consistently available in the electronic or
physical charts. Additionally, there was variation in the
method of diagnosis in our study population. The majority
of diagnoses were made at the time of detailed anatomic
survey by a radiologist or maternal-fetal medicine specialist
with formal training in obstetric ultrasound, but for a
small percentage of the cases we relied on the ultrasound
diagnosis from a different institution, or a less detailed
ultrasound; for ﬁve cases, prenatal imaging information
was missing completely. Another limitation to our study
(and other studies in the literature) is lack of baseline
recurrence risk for each couple’s condition. Finally, this is
a tertiary care center, so results may not be generalizable to
hospitals without highly specialized prenatal diagnostic
services.
Conclusion
Our study reafﬁrms that for the vast majority of cases at our
institution, there is high agreement between prenatal and
autopsy diagnosis after pregnancy termination for fetal
anomalies. There is variation in that concordance according
to anomaly type, for example, autopsy is particularly useful
in the case of musculoskeletal anomalies where fetal ultra-
sound cannot provide the anatomic detail necessary for
accurate diagnosis. Of course, autopsy remains a method of
analyzing quality control for ultrasound. But what is most
meaningful to patients is understanding whether they are at
risk for future pregnancies that may be affected by the same
condition. Further studies that take into account a couple’s
prenatal recurrence risk for speciﬁc conditions would be
useful. Patients should be informed that in most cases,
autopsy may not result in useful information. Such counsel-
ingmay be particularly relevant for womenwho are deciding
to terminate by induction of labor versus dilation and
evacuation (D&E) and feel compelled to choose induction
of labor because they believe it will yield more information
from an autopsy; based on our ﬁndings, desire for an autopsy
should not be a deciding factor.24
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